LAMIVUDINE, ZIDOVUDINE TABS 150MG/300MG CO-PACKAGED WITH NEVIRAPINE TABS 200MG
Pre-Launchlamivudine; zidovudine; nevirapine
NDAORALTABLET
Lifecycle
Pre-Launch
Data completeness
2/8 — Basic
LAMIVUDINE, ZIDOVUDINE TABS 150MG/300MG CO-PACKAGED WITH NEVIRAPINE TABS 200MG (lamivudine; zidovudine; nevirapine) by Hetero is fixed-dose combination of the hiv‑1 antiretroviral agents abacavir, dolutegravir, and lamivudine [see microbiology ()]. Approved for hiv-1 infection in adults, weighing at least 6 kg.
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
This is a fixed-dose combination antiretroviral tablet co-packaging lamivudine 150mg, zidovudine 300mg, and nevirapine 200mg for treatment of HIV-1 infection in adults and pediatric patients weighing at least 6 kg. The combination uses nucleoside reverse transcriptase inhibitors (lamivudine, zidovudine) and a non-nucleoside reverse transcriptase inhibitor (nevirapine) to suppress HIV-1 replication through complementary mechanisms.
Pre-Launch
Early-stage product from Hetero with no current commercial data; career opportunity lies in launch planning and market entry strategy for a crowded FDC HIV segment.
Mechanism of Action
fixed-dose combination of the HIV‑1 antiretroviral agents abacavir, dolutegravir, and lamivudine [see Microbiology ()].
Indications (2)
Worked on LAMIVUDINE, ZIDOVUDINE TABS 150MG/300MG CO-PACKAGED WITH NEVIRAPINE TABS 200MG at Hetero? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.